| protein
| dimerize with ARNT ( |
|
MOP3 ( |
|
SRC-1 and transcription intermediary factor 2, TIF2 ( |
|
von Hippel-Lindau tumor suppressor protein, VHL  |
|
proteasome (prosome, macropain) subunit, alpha type, PSMA7 ( |
|
tumor suppressor p53 ( |
|
Jun activation domain-binding protein-1, JAB1  |
|
period homolog 1 (Drosophila), PER1 ( |
|
functionally cooperates with c-Jun ( |
|
p53 binding protein homolog (mouse), MDM2 ( |
|
Brahma, Brm and Brahma/SWI2-related gene 1, Brg-1 ( |
|
SMT3 suppressor of mif two 3 homolog 1, SUMO1 ( |
|
cysteine-histidine-rich 1, CH1 ( |
|
retinoblastoma protein, pRB ( |
|
osteosarcoma amplified 9, endoplasmic reticulum lectin, OS9 ( |
|
pVHL-interacting deubiquitinating enzyme 2, VDU2 ( |
|
necdin homolog (mouse), NDN ( |
|
ARD1 ( |
|
MSF-A ( |
|
metastasis-associated protein 1, MTA1 ( |
|
testis specific gene antigen 10, TSGA10 ( |
|
beta-catenin ( |
|
Nur77 ( |
|
spermidine/spermine-N(1)-acetyltransferase 2, SSAT2 ( |
|
signal transducer and activator of transcription3, STAT3 ( |
|
RACGAP1 (HIF-1alpha function is negatively affected by its interaction with RACGAP1)  |
|
Reptin  |
|
MCM2, MCM5, MCM3 and MCM7 |
|
HDAC4 regulates HIF1A protein acetylation and stability, via HIF1A N-terminal lysines  |
|
USP19 interacts with components of the hypoxia pathway including HIF1A and rescues it from degradation independent of its catalytic activity  |
| Other
| rapidly degraded by proteasome under normoxic conditions |
|
| regulated by von Hippel-Lindau tumour suppressor protein, VHL ( |
|
| targeted by VALand |
|
| pVHL-interacting protein functions as a negative regulator of HIF-1alpha transactivation ( |
|
| HIF-1& |
| |
945; protein levels downregulated by MCM7 ( |
|
| regulated by proteasome (prosome, macropain) subunit, alpha type, 7, PSMA7 ( |
|
| PARP1 as a transcriptional coactivator of HIF-1-dependent gene expression during tumor progression ( |
|
| epigenetic regulation of CD34 and HIF1A expression during the differentiation of mast cells |
|
| Hif1a-/- mouse embryos with complete deficiency of HIF-1alpha due to homozygosity for a null allele at the Hif1a locus die at midgestation, with multiple cardiovascular malformations and mesenchymal cell death ( | |
transgenic mice expressing constitutively active HIF-1alpha in epidermis displayed hypervascularity with 66% increase in dermal capillaries, a 13-fold elevation of total vascular endothelial growth factor (VEGF) expression, and a six- to ninefold induction of each VEGF isoform ( |
|
partialHIF-1 alpha deficiency has a dramatic effect on carotid body neural activity and ventilatory adaptation to chronic hypoxia in Hif1a(+/-) mice ( |
|
neural cell-specific HIF-1alpha-deficient mice exhibit hydrocephalus accompanied by a reduction in neural cells and an impairment of spatial memory ( |
|
skeletal-muscle HIF-1alpha knockout mice have an altered exercise endurance ( |
|
mice lacking HIF-1alpha in their myeloid cell lineage showed decreased bactericidal activity and failed to restrict systemic spread of infection from an initial tissue focus ( |
|
mice lacking HIF-1alpha in osteoblasts had impaired angiogenesis and bone healing ( |
|
HIF-1alpha- and TWIST-null mice show similarities in their phenotypes (Yang, 2008) |